PUBLICATIONS

Alzheimer’s Disease

2021

Wiesman, A. I., Mundorf, V. M., Casagrande, C. C., Wolfson, S. L., Johnson, C. M., May, P. E., Murman, D. L., & Wilson, T. W. (2021). Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum. EBioMedicine, 73:103638

Wiesman, A. I., Murman, D. L., May, P. E., Schantell, M., Losh, R. A., Johnson, H. J., Willet, M. P., Eastman, J. A., Christopher-Hayes, N. J., Knott, N. L., Houseman, L. L., Wolfson, S. L., Losh, K. L., Johnson, C. M., & Wilson, T. W. (2021). Spatio-spectral relationships between pathological neural dynamics and cognitive impairment along the Alzheimer's disease spectrum. Alzheimer’s & Dementia, 13(1):e12200

Wiesman, A. I., Murman, D. L., May, P. E., Schantell, M., Wolfson, S. L., Johnson, C. M., & Wilson, T. W. (2021). Visuospatial alpha and gamma oscillations scale with the severity of cognitive dysfunction in patients on the Alzheimer's disease spectrum. Alzheimer’s Research & Therapy, 13(1):139

2022

Casagrande, C. C., Wiesman, A. I., Schantell, M., Johnson, H. J., Wolfson, S. L., O'Neill, J., Johnson, C. M., May, P. E., Swindells, S., Murman, D. L., & Wilson, T. W. (2022).  Signatures of somatosensory cortical dysfunction in Alzheimer's disease and HIV-associated neurocognitive disorder.  Brain Communications4(4), fcac169

Springer, S. D., Wiesman, A. I., May, P. E., Schantell, M., Johnson, H. J., Willett, M. P., Castelblanco, C. A., Eastman, J. A., Christopher-Hayes, N. J., Wolfson, S. L., Johnson, C. M., Murman, D. L., & Wilson, T. W. (2022). Altered visual entrainment in patients with Alzheimer's disease: magnetoencephalography evidence.  Brain Communications4(4), fcac198

Springer, S. D., Wiesman, A. I., May, P. E., Schantell, M., Johnson, H. J., Willett, M. P., Castelblanco, C. A., Eastman, J. A., Christopher-Hayes, N. J., Wolfson, S. L., Johnson, C. M., Murman, D. L., & Wilson, T. W. (2022). Altered visual entrainment in patients with Alzheimer's disease: magnetoencephalography evidence. Brain Communications, 1;4(4), fcac198

Schantell, M., Christopher-Hayes, N. J., Johnson, H. J., Willett, M. P., Wolfson, S. L., Losh, K. L., Johnson, C. M., May, P. E., & Wilson, T. W. (2022). Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.  Brain: A Journal of Neurology145(6), 2177–2189

Wiesman, A. I., Murman, D. L., Losh, R. A., Schantell, M., Christopher-Hayes, N. J., Johnson, H. J., Willett, M. P., Wolfson, S. L., Losh, K. L., Johnson, C. M., May, P. E., & Wilson, T.W. (2022). Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.  Brain 145(6):2177-2189

2023

Casagrande, C. C, Rempe, M. P., Springer, S. D., & Wilson, T. W. (2023). Comprehensive review of task-based neuroimaging studies of cognitive deficits in Alzheimer’s Disease using electrophysiological methods. Ageing Research Reviews, 88, 101950

Christopher-Hayes, N.J., Embury, C.M., Wiesman, A.I., May, P.E., Schantell, M., Johnson, C.M., Wolfson, S.L., Murman, D.L., & Wilson, T. W. (2023). Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer’s Disease spectrum. Front Aging Neuroscience 15:121297

Horne, L. K., Schantell, M., Mansouri, A., Springer S. D., Wiesman, A. I., Johnson, H. J., Okelberry, H. J., May, P. E., & Wilson, T. W. (2023). A - 23 neuropsychological assessments are highly predictive of B-amyloid positive Alzheimer’s Disease.  Archives of Clinical Neuropsychology, 38(7), 1185

Meehan, C. E., Schantell, M., Wiesman, A. I., Wolfson, S. L., O'Neill, J., Bares, S. H., Johnson, C. M., May, P. E., Murman, D. L., & Wilson, T. W. (2023). Oscillatory markers of neuroHIV-related cognitive impairment and Alzheimer's Disease during attentional interference processing. Aging15(2), 524–541

Meehan, C. E., Embury, C. M., Wiesman, A. I., Schantell, M., Wolfson, S. L., O'Neill, J., Swindells, S., Johnson, C. M., May, P. E., Murman, D. L., & Wilson, T. W. (2023). Convergent and divergent oscillatory aberrations during visuospatial processing in HIV-related cognitive impairment and Alzheimer's Disease. Cerebral Cortex (New York, N.Y. :1991)33(6), 3181–3192

Meehan, C. E., Schantell, M., Springer, S. D., Wiesman, A. I., Wolfson, S. L., O'Neill, J., Murman, D. L., Bares, S. H., May, P. E., Johnson, C. M., & Wilson, T. W. (2023). Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer’s Disease and HIV-associated neurocognitive disorder. Neurobiology of Disease, 186, 106283

Rempe, M. P., Wiesman, A. I., Murman, D. L., May, P. E., Christopher-Hayes, N. J., Wolfson, S. L., Johnson, C. M., & Wilson, T. W. (2023). Sleep quality differentially modulates neural oscillations and proteinopathy in Alzheimer's Disease. EBioMedicine92, 104610

Springer, S. D., Erker, T. D., Schantell, M., Johnson, H. J., Willett, M. P., Okelberry, H. J., Rempe, M. P., & Wilson, T. W. (2023). Disturbances in primary visual processing as a function of healthy aging.NeuroImage271, 120020

2024

Petro, N. M., Webert, L. K., Springer, S. D., Okelberry, H. J., John, J. A., Horne, L. K., Glesinger, R., Rempe, M. P., & Wilson, T. W. (2024). 
Optimal gamma-band entrainment of visual cortex. Human Brain Mapping; 45(10):e26775

Qu, G., Orlichenko, A., Wang, J., Zhang, G., Xiao, L., Zhang, K., Wilson, T. W., Stephen, J. M., Calhoun, V. D., & Wang, Y. P. (2024). 
Interpretable cognitive ability prediction: A comprehensive gated graph transformer framework for analyzing function brain networks. IEEE Transactions on Medical Imaging; 43(4):1568-1578

Son, J. J., Arif, Y., Oludipe, D., Weyrich, L., Killanin, A. D., Wiesman, A. I., Okelberry, H. J., Willett, M. P., Johnson, H. J., & Wilson, T. W. (2024). 
Multispectral brain connectivity during visual attention distinguishes controlled from uncontrolled hypertension. Journal of Physiology; 602(8):1775-1790

Wiesman, A. I., Gallego-Rudolf, J., Villeneuve, S., Baillet, S., Wilson, T. W., PREVENT-AD Research Group (2024). 
Alignments between clinical neurochemical systems, proteinopathy and neurophysiological alterations along the Alzheimer’s disease continuum. medRxiv Preprint